[The effects of propafenone in the treatment of ventricular arrhythmias with a malignant potential for resistance to conventional anti-arrhythmia medication].
Câmpeanu
A
A
Clinica de boli interne, Spitalul Caritas, Bucureşti.
Rădoi
M
M
Serban-Pârâu
G
G
Pleşca
O
O
Nuţă
M
M
Teodorescu
V
V
Titirigă
M
M
D000789:Angina, Unstable / Q000150:complications / Q000175:diagnosis / Q000188:drug therapy; D000889:Anti-Arrhythmia Agents / Q000037:antagonists & inhibitors*; D001145:Arrhythmias, Cardiac / Q000175:diagnosis / Q000188:drug therapy* / Q000209:etiology; D004305:Dose-Response Relationship, Drug; D004341:Drug Evaluation; D004351:Drug Resistance; D004562:Electrocardiography / Q000187:drug effects; D005260:Female; D006801:Humans; D008297:Male; D008875:Middle Aged; D009203:Myocardial Infarction / Q000150:complications / Q000175:diagnosis / Q000188:drug therapy; D011405:Propafenone / Q000627:therapeutic use*
D000889:Anti-Arrhythmia Agents; D011405:Propafenone
Efectele propafenonei în tratamentul aritmiilor ventriculare cu potenţial malign rezistente la medicaţia anti-aritmică convenţională.